Related Experiment Video

Updated: May 25, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Clinical management considerations for dyslipidemia in HIV-infected individuals

Jeffrey T Kirchner1

  • 1Comprehensive Care Medicine for HIV, Lancaster General Hospital, Lancaster, PA 17602, USA. jtkirchn@lghealth.org

Postgraduate Medicine
|February 9, 2012
PubMed

Insights

Dyslipidemia is common in human immunodeficiency virus (HIV) patients, increasing coronary heart disease (CHD) risk. Management requires careful consideration of antiretroviral therapy, drug interactions, and inflammation for optimal cardiovascular care.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Dyslipidemia is prevalent in patients with human immunodeficiency virus (HIV).
  • This can lead to significant morbidity, including coronary heart disease (CHD).
  • Current treatment guidelines are often based on those for individuals without HIV.

Purpose of the Study:

  • To review the management of dyslipidemia in HIV-infected individuals.
  • To highlight challenges and considerations in treating dyslipidemia in this population.
  • To identify areas for future research.

Main Methods:

  • Review of current guidelines and literature on dyslipidemia management in HIV.
  • Evaluation of cardiovascular risk assessment tools like the Framingham risk calculator.
  • Discussion of treatment strategies including antiretroviral regimen modification and pharmacologic therapy.

Main Results:

  • Treatment strategies should align with established cardiovascular risk assessment.
  • Switching antiretroviral therapy may be considered to improve lipid profiles.
  • Statins are a primary treatment, but drug-drug interactions (e.g., protease inhibitors and statins) require careful management.

Conclusions:

  • Managing dyslipidemia in HIV patients is complex, necessitating individualized care.
  • Drug interactions and the role of chronic inflammation in HIV-associated cardiovascular disease require further investigation.
  • Optimizing lipid management is crucial for reducing cardiovascular morbidity in HIV-infected individuals.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...